Drawing for TAS

USPTO serial 79323870

TAS

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
—
Examiner
BUTLER, MIDGE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TAS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of tumor; pharmaceutical preparations for the treatment of cancer; chemical reagents for medical purposes in the field of oncology; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of dermatological diseases and disorders; pharmaceutical preparations for the treatment of muscular diseases and disorders; pharmaceutical preparations for the treatment of urological diseases and disorders; pharmaceutical preparations for the treatment of digestive diseases and disorders; pharmaceutical preparations for the treatment of gastroesophageal reflux diseases and disorders; pharmaceutical preparations for the treatment of hepatic diseases and disorders; pharmaceutical preparations for the treatment of renal diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of diseases of the central and peripheral nervous system; pharmaceutical preparations for the treatment of rheumatoid arthritis; pharmaceutical preparations for the treatment of diseases of the blood; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations for use in chemotherapy; anti-emetic medicines; pharmaceutical preparations for the treatment of pain; analgesic preparations; antiphlogistic preparations; diagnostic reagents for medical purposes; chemical preparations for pharmaceutical or medical purposes, namely, for tumor or cancer; diagnostic preparations for medical purposesSECTION 70 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 19, 2022LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Aug 22, 2022DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Aug 21, 2022DETHDEATH OF INTERNATIONAL REGISTRATION—
Jun 29, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Jun 20, 2022LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jun 7, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2022NPUBNOTICE OF PUBLICATION—
May 3, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 3, 2022DOCKASSIGNED TO EXAMINER—
Nov 9, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 4, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 22, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance